About
Women's Health
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
1,082
By Phase
PHASE3: 3
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT03840616Lead Sponsor
Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections
PHASE3Completed
219 participants
Started: Mar 13, 2019 · Completed: Dec 2, 2020
NCT03561701Lead Sponsor
A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
PHASE3Completed
425 participants
Started: Aug 23, 2018 · Completed: Aug 3, 2021
NCT03562156Lead Sponsor
A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
PHASE3Completed
438 participants
Started: Aug 16, 2018 · Completed: Aug 6, 2021
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...